A detailed history of Baird Financial Group, Inc. transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Baird Financial Group, Inc. holds 15,691 shares of ORIC stock, worth $130,706. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,691
Previous 12,991 20.78%
Holding current value
$130,706
Previous $91,000 75.82%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$7.52 - $11.9 $20,304 - $32,130
2,700 Added 20.78%
15,691 $160,000
Q2 2024

Aug 13, 2024

BUY
$6.63 - $12.93 $4,309 - $8,404
650 Added 5.27%
12,991 $91,000
Q4 2023

Feb 14, 2024

BUY
$5.41 - $9.43 $66,764 - $116,375
12,341 New
12,341 $113,000

Others Institutions Holding ORIC

About Oric Pharmaceuticals, Inc.


  • Ticker ORIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,576,700
  • Market Cap $330M
  • Description
  • ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...
More about ORIC
Track This Portfolio

Track Baird Financial Group, Inc. Portfolio

Follow Baird Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Baird Financial Group, Inc. with notifications on news.